Michael J. Elmore

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Immunization +16

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Katie Ewer, Jordan R. Barrett, Sandra Belij‐Rammerstorfer et al. · Nature Medicine · 2020 · 643 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Jiandong Huo, Audrey Le Bas, Reinis R. Ruza et al. · Nature Structural & Molecular Biology · 2020 · 550 citations · Full text

Life Sciences, Biomedical Sciences, Immunology +4

Virus genomes reveal factors that spread and sustained the Ebola epidemic

Gytis Dudas, Luiz Max Carvalho, Trevor Bedford et al. · Nature · 2017 · 461 citations · Full text

Life Sciences, Genetics, Infectious Diseases +14